Clinical Trials Search | Clareo Health

About Pricing FAQs Blog

Loading clinical trials...

Clareo Health

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 1-1 of 1 trials

Not Yet Recruiting

Characterization and Contribution of Genome-wide DNA Methylation (DNA Methylation Episignatures) in Rare Diseases With Prenatal Onset

NCT06475651

It is necessary to define reference DNA Methylation Episignatures from fetal DNA. The hypotheses are: * It is possible to define reference DNA Methylation Episignatures from fetal DNA extracted from amniotic fluid or frozen tissues collected during the postmortem examination * Fetal DNA Methylation Episignatures may be different to postanal DNA Methylation Episignatures defined on DNA extracted from blood

Rare Fetal Genetic DiseasesCongenital Malformation

Assistance Publique - Hôpitaux de Paris63 participantsStarted Jun 2024

Paris, France

Data from ClinicalTrials.govTerms